Korian’s Takeover Offer for Curanum Has Been a Great Success
With 78% of the share capital, Korian now has a controlling interest which
will facilitate the combination of Phönix and Curanum to create the new German
This operation strengthens Korian’s position as Europe’s joint leader, with
35,000 beds in operation in Europe, including 57% internationally.
PARIS -- March 8, 2013
Yann Coléou, CEO of Korian (Paris:KORI):
“The acquisition of Curanum marks a significant stage in our growth and
development strategy. It reinforces our status as the joint-leader in Europe
and places us directly in a market-leading position in Germany, a market with
huge potential. Germany is the largest market in Europe, with demographics
that are extremely favourable to our business. It also offers a sustainable
public financing system and future opportunities for consolidation.
The operation was successfully completed thanks to the trust of our
shareholders and the commitment of our teams. It is part of a major corporate
project, Korian First, which aims to make Korian the number one operator in
the market in terms of leadership, progress, quality and innovation.”
On 21 January 2013, the Korian group (“Korian”) published the offer document
for the voluntary public takeover offer to all shareholders of Curanum AG for
the acquisition of all their bearer shares with no par value (ISIN
DE0005240709 (WKN 524070)) of Curanum AG (Curanum-Shares) against payment of a
cash consideration of EUR 2.50 per Curanum-Share. The offer document is
available under http://www.groupe-korian.com/Finance2/Offre-Curanum. On 14
February 2013, Korian has waived the minimum acceptance threshold of 75% for
the takeover offer. As a result of the amendment of the offer, the acceptance
period ended on 4 March 2013, 24.00h Central European Time (CET). All other
conditions of the offer have also been fulfilled.
Until 4 March 2013, 24.00 CET, the takeover offer has been accepted for a
total of 29,826,892 Curanum-Shares. This corresponds to approx. 70.1694 % of
the share capital and the voting rights of Curanum.
At the End of the Acceptance Period, Korian also directly held 3,498,325
Curanum-Shares. This corresponds to approx. 8.23% of the share capital and the
voting rights of Curanum AG.
The total number of Curanum-Shares for which the offer has been accepted plus
the total number of Curanum-Shares held by Korian amount to 33,325,217
Curanum-Shares as of the end of the Acceptance Period. This corresponds to
approx. 78.3994 % of the share capital and the voting rights of Curanum AG.
Curanum-Shareholders who have not accepted the takeover offer until now may
still accept the offer within two weeks after this announcement, accordingly
in the period from 8 March 2013 until 21 March 2013, 24.00h CET.
The Korian Group, founded in 2001, is the European market leader in temporary
and permanent comprehensive care. A private group employing almost 19,000
people, Korian has three platforms established inFrance,ItalyandGermany.
At 31 December 2012, Korian’s 248 facilities represented a combined total of
24,356 beds in service.
*InFrance: 127 retirement homes, 37 follow-up care and rehabilitation
clinics, and 7 psychiatric clinics with a total of 14,684 beds.
*In Europe: 31 facilities inItalywith a total of 4,349 beds, and 46
facilities inGermanywith a total of 5,323 beds in service.
The company has been listed on EuronextParisEurolist Compartment B since
Next release: 27 March 2013 after close of trading
2012 annual results
For more information, please visit our website: www.groupe-korian.com
Korian - 32, rue Guersant - 75017 Paris - France – Tel: +33 1 55 37 52 00 –
Fax: +33 1 55 37 52 01
Louis Guyot, T: + 33 1 55 37 52 11
Alexis Jungels, T: + 33 1 55 37 52 25
Maggie Schelfhaut, T: + 33 1 55 37 52 21
Press spacebar to pause and continue. Press esc to stop.